Intravenous metoclopramide is known to increase the rate of absorption of oral diazepam if administered at the same time. It has been suggested that oral metoclopramide has the same effect. In this study, six healthy volunteers received oral diazepam (0.2 mg/kg) on two separate occasions, either alone or with oral metoclopramide (10 mg), given simultaneously. In contrast to the effects of intravenous m etoclopra m ide, oral metoclopramide did not increase the rate of absorption of oral diazepam.
The increase in gastric motility produced by metoclopramide l might be expected to increase the rate of absorption of a basic drug such as diazepam (pKa = 3.5) by hastening its passage from the stomach into the small intestine. Gamble et al. 2 showed in healthy adults that the administration of intravenous (IV) metoclopramide at the same time as oral diazepam did increase the rate of absorption of the diazepam.
Oral metoclopramide has also been shown to increase the rate of absorption of other drugs given concurrently by the oral route. Drugs for which this has been demonstrated include tetracycline,3 levodopa 4 and paracetamol. 5 In fact a proprietary preparation, Paramax (R), a combination of paracetamol and metoclopramide in a single oral tablet, is marketed for migraine in New Zealand and the United Kingdom to take advantage of this principle.
The combination of oral diazepam and oral metoclopramide has been advocated as a premedication 6 and is commonly used in our institution. It has been suggested that the action of oral diazepam is enhanced by oral metoclopramide, 6 raising the possibility that the rate of absorption of diazepam is increased. This study was designed to investigate the effect of oral metoclopramide on the rate of absorption of oral diazepam.
MATERIALS AND METHODS The subjects were six healthy adult volunteers, three male and three female. The mean age of the subjects was 29 years (SD 3.0), range 25-34, and the mean weight was 67.8 kg (SO 11. 9), range 58-93. Except for two of the females who were taking oral contraceptives, no other medication was used by any of the subjects before or during the study.
Each subject was studied on two occasions, thereby acting as his/her own control. Each subject received 0.2 mg/kg diazepam orally on one occasion, and the same dose of diazepam along with 10 mg oral metoclopramide on the other. At least two weeks separated the two studies. The subjects were randomly allocated into two groups, each group receiving a different order of administration which was also randomly assigned.
All volunteers did not consume food, fluid or tobacco for twelve hours prior to each study and for the duration of the blood sampling. A 16 gauge catheter was placed in a large vein in the left antecubital fossa using a small volume oflignocaine as a local anaesthetic. Following the collection of a predose blood sample, the appropriate medication was given along with 10 ml of water. Heparinised blood samples were then collected every five minutes for the first hour, every ten minutes for the second hour, every fifteen minutes for the third hour and at three-and-a-half and four hours. A minimum of twenty-five samples were collected per subject on each occasion. Each subject remained comfortably seated for the duration of the experiment. Immediately after collection, samples were centrifuged and the plasma stored at -20·C until analysed, which was, in most cases, within one week.
Diazepam was measured in plasma by gas chromatography using flurazepam as the internal standard. A calibration standard of diazepam (285 Jlg/I) was analysed with each batch of samples.
One hundred microlitres of sample was added to 1.0 ml of toluene containing the internal standard (120 Jlg/I) , which was vortexed for 30 seconds, then centrifuged. One microlitre of the upper toluene phase was injected onto the column. Chromatography was performed with a Varian, Model 3700 gas chromatograph fitted with an electron capture detector and a 2 m X 3 mm glass column containing 3% OV-17 on Chromosorb W-HP (100-120 mesh). The carrier gas was nitrogen at a flow rate of 30 mllmin. The injector, detector and column temperatures were 290·, 350· and 270· respectively. The column was conditioned by injecting 1.0 JlI of 0.5% (w/v) dipalmitoyl phosphatidylcholine in ethanol before commencing the chromatographic analyses, in accordance with the method of Rutherford. 7 Quantitation was achieved using a Hewlett-Packard 3390A integrator. Under these conditions, the method had a coefficient of variation of 6.4% at 225 Jlg/I and gave a linear standard curve up to 570 Jlgll.
Pharmacokinetic parameters derived were the half-life of absorption (t'l2 abs), lag-time before drug appeared in plasma (Tlag) and time to peak concentration (Tmax). Two methods were used to determine these parameters. The first involved direct examination of the raw data to determine Tlag and Tmax (accurate to within the spacing of data points). The second involved computerised fitting of each concentrationtime curve to both one-and two-compartment models, with first-order absorption and allowing for a lag-time, using NONLIN. 8 The model which best described the data for each individual was chosen using the F-ratio test, and the tlhabs and Tlag were estimated using this model. The Tmax was read directly from the curve.
Statistical analysis was performed usmg Student's t-test for paired values.
RESULTS
There were no differences between the two treatments in any of the time-related parameters of absorption, regardless of the method of analysis ( Table 1 ). The results from the two methods of analysis also showed good agreement. In addition it should be noted that there was no trend in favour of enhanced absorption with metoclopramide, and in fact mean values were in the opposite direction. A representative example is shown in Figure I .
DISCUSSION
In six healthy adult volunteers we were unable to demonstrate any effect of oral metoclopramide on the rate of systemic availability of oral diazepam. This contrasts with the effect of IV metoclopramide which does increase the rate of systemic availability of oral diazepam. 2 It also contrasts with the studies involving tetracycline, 3 levodopa 4 and paracetamol 5 in which a shortened time to peak concentration was demonstrated when oral metoclopramide was administered concurrently.
Why then is the rate of oral availability of diazepam not affected by oral metoclopramide? The answer may relate to the very rapid absorption that occurs for diazepam, given alone. The time to peak Previous studies have shown marked variation in the rate of absorption of oral diazepam (Tmax = 0.5-1.5 hr).9 Our results are consistent with this (Tmax = 0.37-1.8 hr).
Because the numbers in this study were small, the possibility of missing a small difference arises (i.e. ~-error). However, since there was no trend in the direction of a slower rate of absorption, it is unlikely that greater numbers would yield different results.
Metoclopramide is added to diazepam as a premedication for a variety of reasons. These include anti-emesis, the enhancement of gastric emptying of recently ingested material, and the enhancement of the rate of drug absorption. Our study does not support the hypothesis that diazepam is absorbed more rapidly if metoclopramide is co-administered orally with diazepam. 
